Vitamin D role in endothelial dysfunction development in patients with polycystic ovarian syndrome

Background. The study was aimed to determine the correlation between the blood concentration of vitamin D and factors that influence the function of the endothelium and the hemodynamic of gonads in women with polycystic ovary syndrome (PCOS). Material and methods. Sixty women aged from 18 to 26 year...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: T.L. Arkhypkina, V.A. Bondarenko, L.P. Lyubimovа, I.O. Bielkina, N.F. Velichko
Formato: article
Lenguaje:EN
RU
UK
Publicado: Publishing House Zaslavsky 2021
Materias:
Acceso en línea:https://doaj.org/article/b25c85fb8d304b00ac440a44f334b6a4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b25c85fb8d304b00ac440a44f334b6a4
record_format dspace
spelling oai:doaj.org-article:b25c85fb8d304b00ac440a44f334b6a42021-11-22T11:26:20ZVitamin D role in endothelial dysfunction development in patients with polycystic ovarian syndrome2224-07212307-142710.22141/2224-0721.17.6.2021.243206https://doaj.org/article/b25c85fb8d304b00ac440a44f334b6a42021-10-01T00:00:00Zhttp://iej.zaslavsky.com.ua/article/view/243206https://doaj.org/toc/2224-0721https://doaj.org/toc/2307-1427Background. The study was aimed to determine the correlation between the blood concentration of vitamin D and factors that influence the function of the endothelium and the hemodynamic of gonads in women with polycystic ovary syndrome (PCOS). Material and methods. Sixty women aged from 18 to 26 years were examined: 30 women with a diagnosis of PCOS and 30 healthy women. The blood serum concentration of vitamin D, C-reactive protein (CRP), interleukin-6 (IL-6), homocysteine (Hcy), nitrites/nitrates (NOx), and arginine were investigated. Maximum systolic velocity (Vmax), resistance index (RI), and pulsatility index (PI) were measured with Doppler ultrasound. Cholecalciferol was used in a dose of 4000 IU per day for 12 weeks for the correction of deficiency of vitamin D. Results. The patients with PCOS were found to have a lower (Р < 0.001) average vitamin D than healthy women. The reduction of vitamin D concentration was combined with an increase (P < 0.001) in the average concentration of NOx and a decrease in arginine. It was found a positive association between vitamin D and arginine (r = 0.391; P < 0.05), between NOx and CRP (r = 0.432; P < 0.02), IL-6 (r = 0.476; P < 0.01), Vmax (r = 0.383; P < 0.05), RI (r = 0.369; P < 0.05), PI (r = 0.380; P < 0.05) and reverse correlation with arginine (r = –0.375; P < 0.05). It was not found an association between NOx and vitamin D (r = 0.207; P > 0.05), Hcy (r = 0.176; P > 0.05); between vitamin D and Vmax (r = 0.231; P > 0.05), RI (r = 0.201; P > 0.05), PI (r = 0.181; P > 0.05). The therapy of cholecalciferol level was accompanied by an increase (P < 0.001) in concentrations of vitamin D, arginine (P < 0.05) and a decrease in NOx (P < 0.02), IL-6 (P < 0.05), SRP (P < 0.001), Hcy (P < 0.001), Vmax (P < 0.001), RI (P < 0.001), PI (P < 0.01), quantity of antral follicles (P < 0.001), and the growth of follicles (P < 0.001). However, none of the studied indicators reached the indicators in healthy women. Conclusions. The deficiency of vitamin D is associated with increased markers of chronic inflammation, homocysteine, nitrate/nitrites, reduced concentration of arginine that provokes the development of endothelium dysfunction and, therefore, the hemodynamics disorders and folliculogenesis in the ovary.T.L. ArkhypkinaV.A. BondarenkoL.P. LyubimovаI.O. BielkinaN.F. VelichkoPublishing House Zaslavskyarticlepolycystic ovary syndrome, vitamin d, nitric oxide, arginine, c-reactive protein, interleukin-6, homocysteineDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENRUUKMìžnarodnij Endokrinologìčnij Žurnal, Vol 17, Iss 6, Pp 459-464 (2021)
institution DOAJ
collection DOAJ
language EN
RU
UK
topic polycystic ovary syndrome, vitamin d, nitric oxide, arginine, c-reactive protein, interleukin-6, homocysteine
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
spellingShingle polycystic ovary syndrome, vitamin d, nitric oxide, arginine, c-reactive protein, interleukin-6, homocysteine
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
T.L. Arkhypkina
V.A. Bondarenko
L.P. Lyubimovа
I.O. Bielkina
N.F. Velichko
Vitamin D role in endothelial dysfunction development in patients with polycystic ovarian syndrome
description Background. The study was aimed to determine the correlation between the blood concentration of vitamin D and factors that influence the function of the endothelium and the hemodynamic of gonads in women with polycystic ovary syndrome (PCOS). Material and methods. Sixty women aged from 18 to 26 years were examined: 30 women with a diagnosis of PCOS and 30 healthy women. The blood serum concentration of vitamin D, C-reactive protein (CRP), interleukin-6 (IL-6), homocysteine (Hcy), nitrites/nitrates (NOx), and arginine were investigated. Maximum systolic velocity (Vmax), resistance index (RI), and pulsatility index (PI) were measured with Doppler ultrasound. Cholecalciferol was used in a dose of 4000 IU per day for 12 weeks for the correction of deficiency of vitamin D. Results. The patients with PCOS were found to have a lower (Р < 0.001) average vitamin D than healthy women. The reduction of vitamin D concentration was combined with an increase (P < 0.001) in the average concentration of NOx and a decrease in arginine. It was found a positive association between vitamin D and arginine (r = 0.391; P < 0.05), between NOx and CRP (r = 0.432; P < 0.02), IL-6 (r = 0.476; P < 0.01), Vmax (r = 0.383; P < 0.05), RI (r = 0.369; P < 0.05), PI (r = 0.380; P < 0.05) and reverse correlation with arginine (r = –0.375; P < 0.05). It was not found an association between NOx and vitamin D (r = 0.207; P > 0.05), Hcy (r = 0.176; P > 0.05); between vitamin D and Vmax (r = 0.231; P > 0.05), RI (r = 0.201; P > 0.05), PI (r = 0.181; P > 0.05). The therapy of cholecalciferol level was accompanied by an increase (P < 0.001) in concentrations of vitamin D, arginine (P < 0.05) and a decrease in NOx (P < 0.02), IL-6 (P < 0.05), SRP (P < 0.001), Hcy (P < 0.001), Vmax (P < 0.001), RI (P < 0.001), PI (P < 0.01), quantity of antral follicles (P < 0.001), and the growth of follicles (P < 0.001). However, none of the studied indicators reached the indicators in healthy women. Conclusions. The deficiency of vitamin D is associated with increased markers of chronic inflammation, homocysteine, nitrate/nitrites, reduced concentration of arginine that provokes the development of endothelium dysfunction and, therefore, the hemodynamics disorders and folliculogenesis in the ovary.
format article
author T.L. Arkhypkina
V.A. Bondarenko
L.P. Lyubimovа
I.O. Bielkina
N.F. Velichko
author_facet T.L. Arkhypkina
V.A. Bondarenko
L.P. Lyubimovа
I.O. Bielkina
N.F. Velichko
author_sort T.L. Arkhypkina
title Vitamin D role in endothelial dysfunction development in patients with polycystic ovarian syndrome
title_short Vitamin D role in endothelial dysfunction development in patients with polycystic ovarian syndrome
title_full Vitamin D role in endothelial dysfunction development in patients with polycystic ovarian syndrome
title_fullStr Vitamin D role in endothelial dysfunction development in patients with polycystic ovarian syndrome
title_full_unstemmed Vitamin D role in endothelial dysfunction development in patients with polycystic ovarian syndrome
title_sort vitamin d role in endothelial dysfunction development in patients with polycystic ovarian syndrome
publisher Publishing House Zaslavsky
publishDate 2021
url https://doaj.org/article/b25c85fb8d304b00ac440a44f334b6a4
work_keys_str_mv AT tlarkhypkina vitamindroleinendothelialdysfunctiondevelopmentinpatientswithpolycysticovariansyndrome
AT vabondarenko vitamindroleinendothelialdysfunctiondevelopmentinpatientswithpolycysticovariansyndrome
AT lplyubimova vitamindroleinendothelialdysfunctiondevelopmentinpatientswithpolycysticovariansyndrome
AT iobielkina vitamindroleinendothelialdysfunctiondevelopmentinpatientswithpolycysticovariansyndrome
AT nfvelichko vitamindroleinendothelialdysfunctiondevelopmentinpatientswithpolycysticovariansyndrome
_version_ 1718417755322974208